As your symptoms improve, you might only need them every few months or so
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
Supplement for hair loss, brittle nails and nerve damage
Success rate for chronic plantar fasciitis and Achilles tendinopathy: 7585%
Peptide therapy uses specific ones to support those processes
The information provided in this article is for educational purposes only and should not be construed as medical advice